Jupiter Life Line Hospitals (NSE:JLHL) EBIT: ₹2,929 Mil (TTM As of Mar. 2026)


NSE:JLHL Jupiter Life Line Hospitals Ltd NSE:JLHL
69 GF Score
Price ₹1,456.30
GF Value ₹1,787.54
Valuation Modestly Undervalued
View Full Analysis

What is Jupiter Life Line Hospitals EBIT?

Jupiter Life Line Hospitals NSE:JLHL +0.20% 69 EBIT is ₹2,929 Mil as of Mar. 2026. GuruFocus rates NSE:JLHL with a GF Score™ of 69/100 and a GF Value™ of ₹1,787.54 (Modestly Undervalued).

Jupiter Life Line Hospitals's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was ₹766 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹2,929 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Jupiter Life Line Hospitals's annualized ROC % for the quarter that ended in Mar. 2026 was 11.18%. Jupiter Life Line Hospitals's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 18.85%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Jupiter Life Line Hospitals's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 3.06%.


Jupiter Life Line Hospitals  (NSE:JLHL) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Jupiter Life Line Hospitals's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=2636.24 * ( 1 - 25.59% )/( (0 + 17553.52)/ 1 )
=1961.626184/17553.52
=11.18 %

where

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=23831.29 - 1694.52 - ( 5404.77 - max(0, 2265.75 - 6849+5404.77))
=17553.52

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Jupiter Life Line Hospitals's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=3062.56/( ( (0 + max(0, 0)) + (16247.22 + max(-708.01, 0)) )/ 1 )
=3062.56/( ( 0 + 16247.22 )/ 1 )
=3062.56/16247.22
=18.85 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0 + 0 + 0)
=0

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(755.39 + 383.36 + 240.89) - (1694.52 + 0 + 393.13)
=-708.01

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Jupiter Life Line Hospitals's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=2928.68/95826.447
=3.06 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jupiter Life Line Hospitals EBIT Related Terms


Jupiter Life Line Hospitals EBIT Historical Data

* Premium members only.

The historical data trend for Jupiter Life Line Hospitals's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jupiter Life Line Hospitals EBIT Chart

Jupiter Life Line Hospitals Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBIT
Get a 7-Day Free Trial 1,137.72 1,674.51 2,180.76 2,640.95 2,877.42

Jupiter Life Line Hospitals Quarterly Data
Mar21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 689.33 697.87 820.59 644.58 765.64

NSE:JLHL vs HCA, THC, DVA: EBIT Comparison

For the Medical Care Facilities subindustry, Jupiter Life Line Hospitals's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jupiter Life Line Hospitals EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Jupiter Life Line Hospitals's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Jupiter Life Line Hospitals's EV-to-EBIT falls into.


NSE:JLHL
69GF Score
Jupiter Life Line Hospitals Ltd NSE:JLHL
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jupiter Life Line Hospitals EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹2,929 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ₹2,929 Mil mean?
Jupiter Life Line Hospitals (NSE:JLHL) has a EBIT of ₹2,929 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Jupiter Life Line Hospitals.
Is Jupiter Life Line Hospitals' EBIT too high?
Jupiter Life Line Hospitals' current EBIT is ₹2,929 Mil. Overall, Jupiter Life Line Hospitals has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jupiter Life Line Hospitals' EBIT compare to HCA and THC?
Jupiter Life Line Hospitals' EBIT of ₹2,929 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Jupiter Life Line Hospitals. Jupiter Life Line Hospitals's current EBIT is ₹2,929 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jupiter Life Line Hospitals stock overvalued right now?
Based on GuruFocus' analysis, Jupiter Life Line Hospitals (NSE:JLHL) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹1,787.54, compared to a current price of ₹1,456.30 — trading 18.5% below its estimated fair value. The current EBIT is ₹2,929 Mil. Jupiter Life Line Hospitals' overall GF Score™ is 69/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Jupiter Life Line Hospitals (NSE:JLHL), the current EBIT is ₹2,929 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jupiter Life Line Hospitals (NSE:JLHL) Overvalued in 2026?

Based on GuruFocus' analysis, Jupiter Life Line Hospitals stock appears to be undervalued. The current stock price of ₹1,456.30 is trading 18.5% below its estimated GF Value™ of ₹1,787.54. GuruFocus considers Jupiter Life Line Hospitals to be Modestly Undervalued.

Key valuation signals for NSE:JLHL:

  • EBIT: ₹2,929 Mil
  • GF Value™: ₹1,787.54 vs. price of ₹1,456.30 (18.5% below fair value)
  • GF Score™: 69/100

No single metric tells the full story. See the NSE:JLHL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Jupiter Life Line Hospitals Business Description

Other Exchanges 543980:India
Address Eastern Express Highway, Service Road, Next To Viviana Mall, Thane west, Thane, MH, IND, 400601
Jupiter Life Line Hospitals Ltd is a key multi-specialty tertiary and quaternary healthcare provider. The Company operates in one business and geographical segment that is Medical and Healthcare Services in India. The Hospital revenue comprises of fees charged for inpatient and outpatient hospital services and other hospital services. Services include charges for accommodation, operation theatre, medical professional services, equipment, radiology, laboratory, and pharmaceutical goods used for treating patients.
69GF Score

Get the complete analysis for NSE:JLHL

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,456.30
Price
₹1,787.54
GF Value